Synthetic Lethality Conference, Boston, 2017 Boston, Massachusetts, USA 31 January - 1 February, 2018

Description:
Across 3 content-packed days, the field’s thought leaders from AstraZeneca, Tesaro, Artios, Metabomed, Sierra Oncology and many more will be sharing their insight and lessons learned, collectively enabling the community to.

URLs:
Brochure: https://go.evvnt.com/160417-1
Booking: https://go.evvnt.com/160417-2

Prices:
Conference + 2 Workshops (Industry): USD 4097,
Conference + 1 Workshop (Industry): USD 3398,
Conference Only (Industry): USD 2799,
Workshop Only (Industry): USD 699,
Conference + 2 Workshops (Academic): USD 2868,
Conference + 1 Workshop (Academic): USD 2379,
Conference Only (Academic): USD 1959,
Workshop Only (Academic): USD 699.

Speakers: Graeme Smith - Chief Scientific Officer - Artios Pharma Ltd., J. Carl Barrett - Vice President of Translational science in Oncology - AstraZeneca, Aviad Tsherniak - Associate Director of Cancer Data Science - Broad Institute of MIT and Harvard, Alexandra Grassian - Senior Scientist - Epizyme, Cyril Benes - Director for the Center for Molecular Therapeutics - Mass General Center for Cancer Research, Simone Botti - CEO - Metabomed Ltd., René Bernards - Professor of molecular carcinogenesis - Netherlands Cancer Institute, Bill Forrester - Principal Investigator - Novartis, Dr. Mark Kowalski - Chief Medical Officer - Sierra Oncology, Jeffrey H. Hanke - Executive Vice President of Research and Development and Chief Scientific Officer - TESARO and many more.

Time: 9:00 am to 5:00 pm.